Found 8 matching trials
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer
PHASE2This phase II trial studies how well apalutamide and gonadotropin-releasing...
Location
M D Anderson Cancer Center
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
PHASE2The proposed clinical trial will study the effects of 12 months of therapy ...
Location
Multiple Locations
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
PHASE2This research study is comparing two different combinations of androgen dep...
Location
University of California, San Diego
Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer
NAThe aim of this study is to test the safety and feasibility of SBRT without...
Location
Changhai hospital
Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
PHASE2The goal of this clinical research study is to learn if adding the combinat...
Location
University of Texas MD Anderson Cancer Center
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
PHASE3The main purpose of this study is to determine if the addition of apalutami...
Status
Active Not Recruiting
Location
Arizona Urology Specialists
Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer
PHASE3The main objective of the trial to determine if the combination of apalutam...
Location
Multiple Locations
Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy
PHASE3This is a multicenter, randomized, open label, phase III study comparing th...
Status
Active Not Recruiting
Location
Clinique Claude Bernard